相关实验视频
Updated: Jan 8, 2026

07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
24.2K
杆菌对胃绕道术后边缘的形成的影响:系统性审查和元分析
Arifur Rahman1, Muhammad Mushtaq1, Faisal Nadeem2
1General Surgery, Walsall Manor Hospital, Walsall, GBR.
Cureus
|December 15, 2025
概括
手术前的Helicobacter pylori (HP) 感染不会显著增加Roux-en-Y胃绕道 (RYGB) 后边缘的风险. 这一系统性审查没有发现HP和腹部外科手术患者边缘发育之间的关联.
科学领域:
- 腹部外科 腹部外科
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
背景情况:
- 鲁克斯-en-Y胃绕道 (RYGB) 是一种常见的减肥手术,有效治疗肥胖和相关疾病.
- 边缘是RYGB后的一个已知的并发症.
- 杆菌 (HP) 在RYGB后边缘形成中的作用尚不清楚.
研究的目的:
- 确定手术前HP感染是否是RYGB后边缘发育的风险因素.
- 在RYGB患者中分析HP感染和边缘发病率之间的关联.
主要方法:
- 来自PubMed,Embase和Cochrane数据库的研究的系统审查和元分析.
- 包括七项研究,包括来自255,899名患者的数据.
- 使用随机效应模型进行聚合分析.
主要成果:
- 在RYGB (风险比率 = 1.16,p = 0.86) 之后,在手术前的HP感染和边缘的发病率之间没有发现显著的关联.
- 在包括的研究中观察到实质性的异质性 (I2 = 96.4%).
结论:
- 在RYGB之后,手术前的HP感染似乎不是边缘形成的重要风险因素.
- 可能需要进一步的研究来探索其他导致RYGB患者边缘的因素.
相关概念视频
Peptic Ulcer Disease V: Surgical Management and Nursing Care
786
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
786
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
Peptic Ulcer Disease I: Introduction
711
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
711
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.1K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.1K
Peptic Ulcer Disease IV: Management
401
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
401
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K

